Latest Safety News

Lindian Resources has taken a decisive step forward with a Final Investment Decision on its Kangankunde Rare Earths Project, underpinned by a $91.5 million institutional placement and a strategic partnership with Iluka Resources. The company is on track for production by late 2026, backed by expanded mining licenses and a new owner-operator mining model.

IGO Limited reports improved safety metrics and steady production despite operational headwinds, maintaining a strong balance sheet and positive cash flow.

St Barbara Limited reports steady progress on its Simberi Expansion Project in Papua New Guinea and Atlantic Gold Projects in Canada, despite production challenges and pending regulatory decisions. A recent A$58 million capital raise strengthens its financial position for growth.

Terramin Australia has announced a $38.3 million non-renounceable rights issue to fund key project developments and reduce debt, offering shareholders shares at a 20% discount.

GreenHy2 Limited has launched its PowerSafe Sodium-Ion Battery range tailored for Australian conditions, expanded into turnkey solar and battery solutions, and signed a strategic MOU with Skeleton Technologies to explore advanced energy storage in Australia.

Ioneer Ltd has enhanced the economics of its Rhyolite Ridge Lithium-Boron Project by cutting leach retention time, boosting lithium and boron production and improving key financial metrics with minimal capital cost increase.

Neurizon Therapeutics has secured FDA clearance to resume clinical trials for its lead ALS drug NUZ-001, alongside a $5.2 million capital raise and a key licensing deal with Elanco Animal Health. These developments position the company for a critical growth phase in neurodegenerative disease therapeutics.

Boss Energy reports a record quarterly uranium production at its Honeymoon Project, with costs coming in below FY26 guidance and a robust cash position. The company also announces a leadership change as Matthew Dusci takes the helm as CEO.

Alligator Energy has commenced construction of its pivotal Samphire Field Recovery Trial, marking a significant shift from exploration to development. The company also bolstered its leadership team to support this growth phase and reported promising exploration results at its Big Lake Uranium Project.

Metals X reported a 16.6% decline in tin production at its Renison operation for Q3 2025 due to equipment and processing challenges, while cash reserves rose to $279.5 million. The company continues advancing its Rentails project and maintains strategic investments.

Dimerix Limited reports solid progress in its Phase 3 trial for DMX-200 targeting rare kidney disease FSGS, backed by orphan drug status in Japan and a robust cash position. The company prepares to engage the FDA on new data supporting regulatory approval.

Minerals 260 Limited has expanded its Bullabulling Gold Project drilling program to 110,000 meters following strong high-grade gold intercepts, with an updated resource estimate due in December 2025. Initial metallurgical tests show gold recoveries exceeding 95%, bolstering project economics as the pre-feasibility study advances.